Kostiukova, N. (2023) “CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma”, Experimental Oncology, 43(4), pp. 336–340. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-4.16924.